Intellia Therapeutics Inc buy Morgan Stanley
Start price
13.11.23
/
50%
€21.86
Target price
13.11.24
€79.49
Performance (%)
-29.07%
End price
14.11.24
€15.51
Summary
This prediction ended on 14.11.24 with a price of €15.51. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.07%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -13.629% | -13.629% | 51.817% |
| iShares Core DAX® | -0.372% | 8.404% | 6.759% |
| iShares Nasdaq 100 | 2.269% | 15.232% | 36.176% |
| iShares Nikkei 225® | 1.433% | 14.424% | 43.114% |
| iShares S&P 500 | 1.216% | 10.492% | 27.276% |
Comments by Morgan_Stanley for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Morgan Stanley from $90.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten